Literature DB >> 15136729

Crystal structure of the human T cell receptor CD3 epsilon gamma heterodimer complexed to the therapeutic mAb OKT3.

Lars Kjer-Nielsen1, Michelle A Dunstone, Lyudmila Kostenko, Lauren K Ely, Travis Beddoe, Nicole A Mifsud, Anthony W Purcell, Andrew G Brooks, James McCluskey, Jamie Rossjohn.   

Abstract

The CD3 epsilon gamma heterodimer is essential for expression and function of the T cell receptor. The crystal structure of the human CD3 epsilon gamma heterodimer is described to 2.1-A resolution complexed with OKT3, a therapeutic mAb that not only activates and tolerizes mature T cells but also induces regulatory T cells. The mode of CD3 epsilon gamma dimerization provides a general structural basis for CD3 assembly and maps candidate T cell antigen receptor docking sites, including a duplicated linear region rich in acidic residues that is unique to human CD3 epsilon. OKT3 binds to an atypically small area of CD3 epsilon and has a low affinity for the isolated CD3 epsilon gamma heterodimer. The structure of the OKT3/CD3 epsilon gamma complex has implications for T cell signaling and therapeutic design.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15136729      PMCID: PMC419665          DOI: 10.1073/pnas.0402295101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  A piston model for transmembrane signaling of the aspartate receptor.

Authors:  K M Ottemann; W Xiao; Y K Shin; D E Koshland
Journal:  Science       Date:  1999-09-10       Impact factor: 47.728

2.  Intracellular redistribution of nucleolin upon interaction with the CD3epsilon chain of the T cell receptor complex.

Authors:  D Gil; D Gutiérrez; B Alarcón
Journal:  J Biol Chem       Date:  2000-12-13       Impact factor: 5.157

3.  Recruitment of Nck by CD3 epsilon reveals a ligand-induced conformational change essential for T cell receptor signaling and synapse formation.

Authors:  Diana Gil; Wolfgang W A Schamel; María Montoya; Francisco Sánchez-Madrid; Balbino Alarcón
Journal:  Cell       Date:  2002-06-28       Impact factor: 41.582

Review 4.  Immunotherapy of insulin-dependent diabetes mellitus.

Authors:  Emma L Masteller; Jeffrey A Bluestone
Journal:  Curr Opin Immunol       Date:  2002-10       Impact factor: 7.486

5.  A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity.

Authors:  Lars Kjer-Nielsen; Craig S Clements; Anthony W Purcell; Andrew G Brooks; James C Whisstock; Scott R Burrows; James McCluskey; Jamie Rossjohn
Journal:  Immunity       Date:  2003-01       Impact factor: 31.745

Review 6.  A new trigger for T cells.

Authors:  Mark M Davis
Journal:  Cell       Date:  2002-08-09       Impact factor: 41.582

7.  Mechanisms contributing to T cell receptor signaling and assembly revealed by the solution structure of an ectodomain fragment of the CD3 epsilon gamma heterodimer.

Authors:  Z J Sun; K S Kim; G Wagner; E L Reinherz
Journal:  Cell       Date:  2001-06-29       Impact factor: 41.582

8.  Heterodimeric CD3epsilongamma extracellular domain fragments: production, purification and structural analysis.

Authors:  K S Kim; Z Y Sun; G Wagner; E L Reinherz
Journal:  J Mol Biol       Date:  2000-09-29       Impact factor: 5.469

9.  Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial.

Authors:  Tammy O Utset; Julie A Auger; Donna Peace; Robert A Zivin; Danlin Xu; Linda Jolliffe; Maria-Luisa Alegre; Jeffrey A Bluestone; Marcus R Clark
Journal:  J Rheumatol       Date:  2002-09       Impact factor: 4.666

10.  The organizing principle in the formation of the T cell receptor-CD3 complex.

Authors:  Matthew E Call; Jason Pyrdol; Martin Wiedmann; Kai W Wucherpfennig
Journal:  Cell       Date:  2002-12-27       Impact factor: 41.582

View more
  66 in total

Review 1.  Structural biology of the T-cell receptor: insights into receptor assembly, ligand recognition, and initiation of signaling.

Authors:  Kai W Wucherpfennig; Etienne Gagnon; Melissa J Call; Eric S Huseby; Matthew E Call
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03-17       Impact factor: 10.005

2.  A novel bispecific antibody format enables simultaneous bivalent and monovalent co-engagement of distinct target antigens.

Authors:  Gregory L Moore; Cristina Bautista; Erik Pong; Duc-Hanh T Nguyen; Jonathan Jacinto; Araz Eivazi; Umesh S Muchhal; Sher Karki; Seung Y Chu; Greg A Lazar
Journal:  MAbs       Date:  2011-11-01       Impact factor: 5.857

3.  Highly enhanced cytotoxicity of a dimeric bispecific diabody, the hEx3 tetrabody.

Authors:  Ryutaro Asano; Keiko Ikoma; Yukiko Sone; Hiroko Kawaguchi; Shintaro Taki; Hiroki Hayashi; Takeshi Nakanishi; Mitsuo Umetsu; Yu Katayose; Michiaki Unno; Toshio Kudo; Izumi Kumagai
Journal:  J Biol Chem       Date:  2010-05-05       Impact factor: 5.157

4.  A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cells.

Authors:  Uwe Reusch; Johannes Duell; Kristina Ellwanger; Carmen Herbrecht; Stefan Hj Knackmuss; Ivica Fucek; Markus Eser; Fionnuala McAleese; Vera Molkenthin; Fabrice Le Gall; Max Topp; Melvyn Little; Eugene A Zhukovsky
Journal:  MAbs       Date:  2015       Impact factor: 5.857

5.  Crystal structure of a human CD3-epsilon/delta dimer in complex with a UCHT1 single-chain antibody fragment.

Authors:  Kelly L Arnett; Stephen C Harrison; Don C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-08       Impact factor: 11.205

6.  Humanizing animal models: a key to autoimmune diabetes treatment.

Authors:  Damien Bresson; Matthias von Herrath
Journal:  Sci Transl Med       Date:  2011-02-02       Impact factor: 17.956

Review 7.  Symmetry breaking: bispecific antibodies, the beginnings, and 50 years on.

Authors:  Gert Riethmüller
Journal:  Cancer Immun       Date:  2012-05-01

8.  Potential aggregation prone regions in biotherapeutics: A survey of commercial monoclonal antibodies.

Authors:  Xiaoling Wang; Tapan K Das; Satish K Singh; Sandeep Kumar
Journal:  MAbs       Date:  2009-05-29       Impact factor: 5.857

9.  Public and private human T-cell clones respond differentially to HCMV antigen when boosted by CD3 copotentiation.

Authors:  Laura R E Becher; Wendy K Nevala; Shari Lee Sutor; Megan Abergel; Michele M Hoffmann; Christopher A Parks; Larry R Pease; Adam G Schrum; Svetomir N Markovic; Diana Gil
Journal:  Blood Adv       Date:  2020-11-10

10.  The quality of chimpanzee T-cell activation and simian immunodeficiency virus/human immunodeficiency virus susceptibility achieved via antibody-mediated T-cell receptor/CD3 stimulation is a function of the anti-CD3 antibody isotype.

Authors:  Frederic Bibollet-Ruche; Brett A McKinney; Alexandra Duverger; Frederic H Wagner; Aftab A Ansari; Olaf Kutsch
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.